Primobolan: The Honest Bloodwork of the "Mild" Compound

Four properties drive the entire bloodwork picture. Zero aromatization comes first: methenolone cannot convert to estrogen, so estradiol falls as your natural testosterone falls. Second, it is a strong SHBG suppressor, which means free androgen fraction rises even at "low" doses. Third, it is 5-alpha-stable, so it does not convert to DHT, and that keeps androgenic sides low. Fourth, it still suppresses gonadotropins. Your testicles do not care that the compound is mild, they simply read "androgen present" and shut down LH and FSH.

The SHBG suppression deserves its own paragraph because it fools people twice. First, it makes total testosterone look higher than it is on a TRT base, because free T rises disproportionately. Second, it makes estradiol look lower than it feels, because free E2 also rises. On 400 mg/week Primo, SHBG can drop 50-60% within 4 weeks. That means your free androgen index climbs even as total T falls. The practical trap: you feel fine at week 4, so you skip the week-8 draw. Then HDL is 22 and you have no idea when it crossed the line. Always measure SHBG at baseline and week 8. It explains half the symptoms you will otherwise misattribute.

The practical consequence: on a Primo-only cycle at 400 mg/week, total testosterone collapses to castrate-range within 2-3 weeks, estradiol follows it down, and every estrogen-protective mechanism loses its support, including HDL metabolism, bone density, mood stability, and lipid clearance. The gains are slow, the sides are quiet, and the bloodwork drift is relentless.

Primo's HDL impact is the most under-appreciated number in the "mild compound" conversation. Because it does not aromatize, there is no estrogen to support hepatic HDL production, and methenolone itself activates hepatic lipase, the enzyme that clears HDL from circulation. At 400 mg/week, HDL drops of 30-45% from baseline are typical. At 600-800 mg/week (the forum "sweet spot" for a lean bulk), drops of 50%+ are common.

The HDL drop is not linear. The first 4 weeks tend to account for the bulk of the total decline. A user starting at 45 mg/dL will often see 35 by week 4, then 28 by week 8, then plateau around 24-26 by week 12. That plateau is the liver's new steady state under hepatic lipase activation. You can slow the early drop with 3-4 grams of omega-3s daily and 30 minutes of zone 2 cardio, but you will not stop it. The only real fix is dose reduction or cessation. If you are stacking Primo with any other DHT derivative, expect the drop to be additive. Plan your cycle knowing that HDL recovery takes 6-8 weeks after the last shot, not 2.

When you stack 400 mg/week of Primo against 500 mg/week of testosterone, the HDL hit lands about the same. But testosterone users at least keep estrogen's partial protection in the picture. Primo users take the full lipid damage with none of that cushion. Once HDL sits below 25 mg/dL for 12+ weeks straight, ApoB particle clearance measurably degrades, and cardiovascular risk stops being theoretical.

On Primo, estradiol falls because testosterone falls. There is no aromatization adding to the pool. Forum wisdom says Primo is "estrogen-free so you need no AI," and that is half right: no AI is correct. The dangerous half is the follow-up advice to "run Primo with just enough test to keep E2 in range." What actually happens: users add 100-150 mg of testosterone to "top up" E2, the test aromatizes, and now they hold an AI in one hand and a compound list growing by the week.

The AI mistake is one of the most common Primo errors. A user runs 400 mg Primo with 200 mg test, sees E2 at 18 pg/mL on the sensitive assay, and panics because the reference range says 30-60. They add 0.25 mg anastrozole twice a week. Two weeks later, E2 is 8, joints ache, mood is flat, and HDL has dropped another 5 points. The AI did nothing for HDL, but it crushed the last bit of estrogenic protection. The rule: on Primo, never add an AI unless E2 is above 30 with symptoms. If E2 is below 20 and you feel fine, leave it. If you feel bad, reduce the Primo or the test, not the estrogen. The number is not the enemy; the symptom is.

The GearCheck interpretation rule applies: treat the patient, not the number. An E2 of 15 pg/mL on Primo-only with good lipids, stable mood, and normal joint comfort is acceptable. The same E2 of 15 pg/mL with crashing HDL, joint pain, and low libido is a signal to reduce the compound load, not to inject more estrogen-support drugs. The AI question on Primo has a one-word answer: no.

Every androgen stimulates erythropoiesis, and methenolone is no exception. The rise is slower than with testosterone or EQ. Primo users typically gain 2-4 points of hematocrit over a 12-week run rather than the 6-8 points EQ is famous for. That slower curve is exactly why it gets ignored. Nobody feels a 51% hematocrit, and a user who checks blood work at week 2 sees nothing and stops checking.

Hematocrit on Primo is a slow creep, but it interacts with TRT in a specific way. If you are on a stable TRT dose of 100-150 mg/week and add 300 mg Primo, your hematocrit will rise from your TRT baseline, not from zero. A TRT user sitting at 47% can hit 51% by week 8. The mistake is assuming the Primo is too low to matter. It is not. The combination of exogenous testosterone and methenolone both stimulate erythropoietin, and the effect is additive. Check hematocrit at week 4, not week 8. If it is already 50%, you have two weeks to add cardio and hydration before you hit the warning zone. Do not wait for symptoms; there are none until the clot.

Methenolone is not 17-alpha-alkylated, the oral version is but the injectable is not, so injectable Primo is one of the least hepatotoxic AAS available. On injectable-only runs, ALT and AST should stay within 20% of baseline. If they climb, check CK for training-driven muscle leak or look at oral stacking before blaming the compound. GGT is the tiebreaker: GGT elevation points to real hepatic stress, while isolated ALT/AST with normal GGT usually points to muscle.

Liver enzymes on injectable Primo are usually clean, but the oral version is a different animal. Oral methenolone acetate is 17-alpha-alkylated and will push ALT and AST 2-3x above baseline within 4 weeks. If you are running oral Primo, you need GGT and bilirubin in the panel, not just ALT and AST. The injectable is the bloodwork-friendly choice, but even then, training-induced muscle leak can confound the picture. If ALT is elevated but CK is also high, the liver is fine. If ALT is high and CK is normal, suspect the compound. The practical rule: never interpret liver enzymes without CK. One hard leg day can double ALT and send you into a panic that ends a perfectly good cycle.

Kidney markers similarly tend to stay clean on injectable Primo. If you're stacking Primo with anything oral, cystatin C is the marker to watch. Creatinine will read high from muscle mass regardless, but cystatin C, which is not produced by muscle, separates athlete-pseudokeness from real renal load.

Primo's drift is slow, so four blood draws will cover a 12-16 week run. Each checkpoint has its own set of values that matter, and here is the schedule.